Korean red ginseng extract enhances paclitaxel distribution to mammary tumors and its oral bioavailability by P-glycoprotein inhibition

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/00498254.2016.1182233PMID 27189791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics

  2020influential reference
• Korean red ginseng ameliorated experimental pancreatitis through the inhibition of hydrogen sulfide in mice.

  2016cited by this paper
• Chemoprevention for Breast Cancer

  2015cited by this paper
• Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp

  2015cited by this paper
• Ginseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice

  2015cited by this paper
• Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein.

  2015cited by this paper
• ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

  2014cited by this paper
• Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel.

  2014influential reference
• Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation

  2014cited by this paper
• Effects of Korean red ginseng extract on acute renal failure induced by gentamicin and pharmacokinetic changes by metformin in rats.

  2013cited by this paper
• Phytochemical analysis and anticancer capacity of Shemamruthaa, a herbal formulation against DMBA- induced mammary carcinoma in rats.

  2013cited by this paper
• Effects of morin on the pharmacokinetics of etoposide in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in female Sprague-Dawley rats.

  2013cited by this paper
• Small and Innovative Molecules as New Strategy to Revert MDR

  2013cited by this paper
• Protective effects of Korean red ginseng against radiation-induced apoptosis in human HaCaT keratinocytes

  2013cited by this paper
• Mass production of the ginsenoside Rg3(S) through the combinative use of two glycoside hydrolases.

  2013cited by this paper
• Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer

  2013cited by this paper
• P-glycoprotein-ATPase modulation: the molecular mechanisms.

  2012cited by this paper
• Chemoprevention for breast cancer.

  2012cited by this paper
• Effects of cysteine on the pharmacokinetics of paclitaxel in rats

  2012cited by this paper
• Stereoselective Regulations of P-Glycoprotein by Ginsenoside Rh2 Epimers and the Potential Mechanisms From the View of Pharmacokinetics

  2012cited by this paper
• Inhibitory Effects of Combination of Lycopene and Genistein on 7,12- Dimethyl Benz(a)anthracene-Induced Breast Cancer in Rats

  2011cited by this paper
• Development and Validation of a Higher-Throughput Equilibrium Dialysis Assay for Plasma Protein Binding

  2011cited by this paper
• Selective inhibition of MDR1 (ABCB1) by HM30181 increases oral bioavailability and therapeutic efficacy of paclitaxel.

  2010cited by this paper
• Cellular Uptake of Ginsenosides in Korean White Ginseng and Red Ginseng and Their Apoptotic Activities in Human Breast Cancer Cells

  2010cited by this paper
• P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity.

  2010cited by this paper
• Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer

  2008cited by this paper
• Gene therapy for breast cancer. — review of clinical gene therapy trials for breast cancer and mdr1 gene therapy trial in cancer institute hospital

  2006cited by this paper
• Pharmacokinetics of combined doxorubicin and paclitaxel in mice.

  2005influential reference
• Analysis methods of ginsenosides.

  2004cited by this paper
• Determination of subcutaneous tumor size in athymic (nude) mice

  2004cited by this paper
• Transcriptional regulation of ABC drug transporters

  2003cited by this paper
• Reversal of P-Glycoprotein-Mediated Multidrug Resistance by Protopanaxatriol Ginsenosides from Korean Red Ginseng

  2003cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Rational use of in vitro P-glycoprotein assays in drug discovery.

  2001cited by this paper
• Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

  1999cited by this paper
• Analysis of enzyme progress curves by nonlinear regression.

  1995cited by this paper
• Gene therapy

  1993cited by this paper
• Role of tamoxifen in the induction of hormone-independent rat mammary tumors.

  1992cited by this paper
• Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism

  1983influential reference
• Clinical biochemical and hematological reference values in normal experimental animals and normal humans

  1981influential reference
• Clinical biochemical and hematological reference values in normal experimental animals

  1977cited by this paper
• Commentary: a physiological approach to hepatic drug clearance.

  1975cited by this paper
• A physiological approach to hepatic drug clearance

  1975cited by this paper

• Herb-drug interactions in oncology: pharmacodynamic/pharmacokinetic mechanisms and risk prediction

  2025cites this paper
• P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators.

  2024cites this paper
• Anti-cancer effects of DHP107 on canine mammary gland cancer examined through in-vitro and in-vivo mouse xenograft models

  2024cites this paper
• Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone Acetylation State

  2023cites this paper
• Treatment failure shortcomings, possible causes and upcoming phyto-optimism in oral cancer

  2023cites this paper
• Systemic and molecular analysis dissect the red ginseng induction of apoptosis and autophagy in HCC as mediated with AMPK

  2023cites this paper
• Synthesis of green carbon dots as bioimaging agent and drug delivery system for enhanced antioxidant and antibacterial efficacy

  2022cites this paper
• Anticolon Cancer Effect of Korean Red Ginseng via Autophagy- and Apoptosis-Mediated Cell Death

  2022cites this paper
• Phytochemicals That Interfere With Drug Metabolism and Transport, Modifying Plasma Concentration in Humans and Animals

  2022cites this paper
• Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy

  2021cites this paper
• Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy.

  2020cites this paper
• Synthesis of a novel green carbon dots as a bioimaging agent and a drug delivery system for enhanced antioxidant and antibacterial efficacy

  2020cites this paper
• Effect of treatment period with LC478, a disubstituted adamantayl derivative, on P-glycoprotein inhibition: its application to increase docetaxel absorption in rats

  2019cites this paper
• LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats

  2019cites this paper
• Herbal Medicines as Adjuncts to Cancer Chemotherapy—Part 1: Immunomodulators

  2019cites this paper
• Bioactivity-guided isolation of ginsenosides from Korean Red Ginseng with cytotoxic activity against human lung adenocarcinoma cells

  2018cites this paper
• Comparison of anticancer activities of Korean Red Ginseng-derived fractions

  2017cites this paper
• Pharmacokinetic characterization of anhuienoside C and its deglycosylated metabolites in rats

  2017cites this paper